3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Status
Completed
14
Terminated
8
Unknown
2
Recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
283
Lymphoid
14
Other solid neoplasm
11
Thoracic
6
Tumor-Agnostic
4
Head & Neck
2
Gynecologic
2
Breast
2
Sarcoma
1
Plasma cell
1
Other hematologic neoplasm
1
Other
1
Genitourinary
1
Dermatologic
1
CNS
1
Conditions
Breast Neoplasms
2
Triple Negative Breast Neoplasms
1
Interventions
Capecitabine
88
Cyclophosphamide
87
Trastuzumab
81
Docetaxel
81
Paclitaxel
65
pyrotinib
55
Epirubicin
55
Tamoxifen
53
Letrozole
51
Fulvestrant
48
Vinorelbine
43
Carboplatin
42
Doxorubicin
41
Radiotherapy
33
exemestane
31
Anastrozole
31
Neoadjuvant Therapy
29
palbociclib
27
Drug Therapy
27
Fluorouracil
24
Bevacizumab
24
pertuzumab
23
Cisplatin
23
eribulin
22
130-nm albumin-bound paclitaxel
21
Goserelin
20
Gemcitabine
20
Exercise
20
Chemotherapy, Adjuvant
19
liposomal doxorubicin
17
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Unknown
×
Oxaliplatin
×
Breast
×
Clear all
NCT01528826
2012-02-08
NVBOX
Fudan University
Phase 2
Unknown
35 enrolled
NCT01351597
2011-05-11
STORM
Korean Breast Cancer Study Group
Phase 2
Unknown
51 enrolled